Clinical trial
Impact of V.A.C. Veraflo Therapy in Wounds Requiring Debridement Within an Orthopedic Practice
NCT02266771 is registered in ClinicalTrials.gov with LifeBridge Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of V.A.C. Veraflo Therapy in Wounds Requiring Debridement Within an Orthopedic Practice
- Lead sponsor
- LifeBridge Health
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2014
- Completion date
- December 31, 2017
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.